U.S. issues Manitoba travel advisory amid hepatitis A outbreak

The United States has issued a travel advisory for Canada’s Manitoba province in response to a growing hepatitis A outbreak that has generated hundreds of infections, several deaths and expanded vaccination campaigns across northern and urban communities.

Cross-border advisory as Manitoba outbreak deepens

Publicly available information indicates that the advisory, issued through the U.S. Centers for Disease Control and Prevention’s Travelers’ Health channels, draws attention to sustained transmission of hepatitis A in Manitoba and urges American travelers to review their vaccination status before visiting the province. The notice characterizes Manitoba as an area with an ongoing outbreak, rather than an isolated cluster, and advises routine precautions for food, water and close personal contact.

Reports from Canadian public health bulletins show that Manitoba has accounted for a disproportionate share of hepatitis A cases nationally over the past year, with infections linked both to northern First Nations communities and populations experiencing homelessness in Winnipeg and other urban centers. Provincial documents describe “locally acquired” cases, indicating that transmission is occurring within Manitoba rather than being driven primarily by international travel.

The U.S. advisory aligns with a broader pattern in which health agencies highlight regional outbreaks that may intersect with common travel routes. Manitoba’s position as a gateway between the U.S. Midwest and northern Canada, along with its role as a hub for road and air travel to remote communities, appears to have elevated concern about cross-border spread, particularly among unvaccinated travelers.

While the advisory does not restrict travel, the emphasis on vaccination and careful hygiene signals a higher level of vigilance. Travelers are encouraged by published guidance to consider hepatitis A immunization if they have not previously received it, and to be alert for symptoms such as fatigue, nausea, abdominal discomfort and jaundice after potential exposure.

Who is most at risk in the Manitoba outbreak

Manitoba Health has issued multiple technical updates since late 2025 expanding eligibility for publicly funded hepatitis A vaccination to groups identified as being at elevated risk. These include residents of several northern First Nations, people experiencing homelessness or unstable housing, individuals who use illicit drugs and workers who have frequent close contact with these communities. The repeated expansions suggest that the outbreak has persisted and spread across social and geographic lines.

Provincial correspondence circulated to health-care providers notes that new cases continue to emerge despite earlier vaccination campaigns, prompting further broadening of who can receive the vaccine at no cost. The documents highlight the goal of reaching individuals who may have limited access to primary care or difficulty completing standard immunization schedules.

According to technical summaries from Manitoba Health, many of the affected communities face overlapping challenges such as crowded housing, limited access to clean water or sanitation in some remote areas, and higher rates of underlying health conditions. These factors can increase the likelihood of both transmission and complications once someone is infected with hepatitis A.

The U.S. advisory reflects these patterns by drawing particular attention to travelers who may have close contact with local residents, including those visiting friends and relatives, volunteers, and people working in health, social services or food handling. Guidance indicates that vaccinated travelers are significantly better protected, but are still advised to maintain careful hygiene throughout their trip.

How hepatitis A spreads and what travelers can do

Hepatitis A is a viral infection of the liver, typically spread through the fecal-oral route. Public health resources in both Canada and the United States describe several common pathways of transmission, including consuming food or water contaminated with the virus, close household or sexual contact with an infected person, and exposure to surfaces that have not been adequately cleaned.

Unlike hepatitis B and C, hepatitis A does not cause chronic infection, but illness can be severe and occasionally fatal, especially in older adults or individuals with pre-existing liver disease. Symptoms often begin suddenly and may include fever, fatigue, loss of appetite, nausea, vomiting, dark urine, pale stools and yellowing of the skin or eyes.

Travel health guidance for the Manitoba advisory emphasizes several practical steps: frequent handwashing with soap and water, especially before eating and after using the bathroom; avoiding the sharing of drinks, utensils or personal items; and exercising caution with food purchased from informal vendors or prepared in settings where sanitation is uncertain. For many travelers, particularly those born after the routine introduction of hepatitis A vaccine, confirming immunization status before departure is presented as the most effective prevention measure.

The advisory also notes that post-exposure vaccination and, in some situations, immune globulin can reduce the risk of developing illness if administered within a limited window after contact with the virus. Travelers who suspect they may have been exposed while in Manitoba are urged by public guidance to seek medical assessment promptly upon return to the United States.

Implications for tourism and cross-border movement

Tourism and business travel between the northern United States and Manitoba typically peaks in the late spring and summer months, driven by outdoor recreation, family visits and trade-related trips. Industry observers suggest that a health advisory of this type may cause some travelers to reconsider or delay nonessential visits, particularly among those with underlying health conditions or incomplete vaccination histories.

Travel-sector reporting indicates that Manitoba’s hospitality businesses, already navigating recent economic pressures, are monitoring public health messaging closely. While there is no formal restriction on entry for U.S. visitors, the presence of a named outbreak and a corresponding advisory can influence destination choices, especially when travelers compare perceived risks among Canadian provinces.

Cross-border communities along the Manitoba–U.S. boundary may also feel indirect effects. Residents of Minnesota and North Dakota who routinely drive to Winnipeg or northern Manitoba for shopping, work or recreation must weigh the inconvenience of arranging vaccination against the benefits of maintaining long-standing travel patterns. In many cases, the advisory may simply prompt conversations with health-care providers before planned trips.

Publicly available economic analyses of previous health-related travel notices suggest that impacts often depend on the duration of the advisory and the visibility of media coverage. If Manitoba’s outbreak is contained and case numbers decline, analysts expect any downturn in visitor numbers to be temporary. A prolonged period of elevated transmission, by contrast, could influence tour operators and conference planners who are currently selecting destinations for the next several seasons.

Monitoring the next phase of the outbreak

Manitoba health authorities continue to release periodic updates outlining case counts, geographic spread and adjustments to vaccine eligibility. Recent documents show additional northern communities being added to the outbreak response, as well as ongoing efforts to bring vaccination clinics directly into affected neighborhoods and encampments.

In parallel, the U.S. advisory may be revised as the situation evolves. CDC travel notices are typically updated when transmission patterns shift, new risk factors are identified or vaccination recommendations change. Observers note that any marked reduction in new cases, especially in high-risk communities, could allow the advisory level to be lowered or withdrawn.

For now, both Canadian and U.S. public health materials frame the Manitoba outbreak as a reminder that vaccine-preventable diseases can still emerge in high-income countries when immunity gaps and social vulnerabilities intersect. Travelers, policy makers and health systems are being urged through published guidance to treat hepatitis A prevention as part of a broader approach to protecting people in precarious living situations.

With peak travel season approaching, the trajectory of Manitoba’s outbreak and the response to the U.S. advisory will likely shape how residents and visitors think about infectious disease risk in what is typically marketed as a low-risk, year-round destination. The coming months are expected to reveal whether intensified vaccination and hygiene efforts can bring the outbreak under control without significantly dampening the province’s appeal to cross-border travelers.